Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Photosensitivity Disorders 1Mesothelioma, Malignant 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma in Situ 1

Interventions

Pemetrexed 4Cisplatin 4tislelizumab 1rilotumumab 1regorafenib 1pembrolizumab 1defactinib 1atezolizumab 1Vorinostat 1Trioxsalen 1Tomography, Optical Coherence 1Photochemotherapy 1Paclitaxel 1LMB-100 1Gemcitabine 1Dihematoporphyrin Ether 1Cytoreduction Surgical Procedures 1Cryotherapy 1Carboplatin 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Mesothelioma, Malignant × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT02106559 2019-03-21

Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy

Ohio State University Comprehensive Cancer Center

Phase NA Withdrawn
Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡